OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

KYOWA KIRIN CO. LTD./  JP3256000005  /

Hannover
10/06/2024  08:00:42 Chg. +0.200 Volume Bid15:29:04 Ask15:29:04 Market Capitalization Dividend Y. P/E Ratio
15.900EUR +1.27% 0
Turnover: 0.000		 15.900Bid Size: 1,766 16.500Ask Size: 304 8.65 bill.EUR - -
GlobeNewswire 30/05 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 23/05 Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first pote...
GlobeNewswire 22/05 Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire 21/05 Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire 16/05 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire 15/05 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 14/05 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 08/05 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 07/05 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...
GlobeNewswire 07/05 Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
GlobeNewswire 03/05 Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024...
GlobeNewswire 02/05 Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 02/05 Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 02/05 BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire 01/05 Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Ch...
GlobeNewswire 23/04 AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval...
GlobeNewswire 18/04 Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
GlobeNewswire 10/04 Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as Pr...
GlobeNewswire 28/03 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 25/03 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
GlobeNewswire 20/03 Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Ap...
GlobeNewswire 18/03 Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy ...
GlobeNewswire 14/03 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 12/03 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 27/02 Ardelyx to Participate at the Cowen 44th Annual Health Care Conference